Two-Dimensional and Three-Dimensional Transthoracic Echocardiography as Predictive and Prognostic Indicators of All-Cause Mortality in Heart Failure with Reduced Ejection Fraction in Patients with Ischemic Heart Disease
- PMID: 32506070
- PMCID: PMC7299062
- DOI: 10.12659/MSM.922129
Two-Dimensional and Three-Dimensional Transthoracic Echocardiography as Predictive and Prognostic Indicators of All-Cause Mortality in Heart Failure with Reduced Ejection Fraction in Patients with Ischemic Heart Disease
Abstract
BACKGROUND This study aimed to compare the predictive role of two-dimensional transthoracic echocardiography (2D-TTE) and three-dimensional transthoracic echocardiography (3D-TTE) on in-hospital all-cause mortality in patients with heart failure and reduced ejection fraction (HFrEF) due to ischemic heart disease (IHD). MATERIAL AND METHODS Patients (N-224) with HFrEF due to IHD who had a left ventricular ejection fraction (LVEF) <40% on admission when measured by 2D-TTE and 3D-TTE were studied and divided into survival and mortality groups. Baseline demographic and clinical characteristics were compared. RESULTS Compared with the survival group (n=142), patients who died during hospitalization (n=82) were more commonly older (67.3 vs. 62.6 years), female (48.8% vs. 38.7%), with diabetes mellitus (51.2% vs. 32.4%), chronic kidney disease (48.8% vs. 32.4%), intravenous inotropes (85.4% vs. 76.1%), and intravenous vasodilators (70.7% vs. 61.3%). Regression model analysis for all-cause mortality identified significant associations with age, diabetes mellitus, myocardial infarction (MI), intravenous inotropes, N-terminal pro-B-type natriuretic peptide (NT-proBNP), and LVEF following 2D-TTE. Age, diabetes mellitus, prior MI, the use of intravenous inotropes, NT-proBNP, LVEF, and left ventricular end-diastolic volume (LVEDV) index following 3D-TTE were significantly associated with all-cause mortality. Modeling of 2D-TTE parameters showed that the concordance statistic (C-index) increased significantly after including the LVEF, from 0.72 to 0.77 and from 0.72 to 0.80, respectively. Modeling of 3D-TTE parameters showed that the C-index increased significantly after including the LVEDV index (from 0.80 to 0.76). CONCLUSIONS In patients with HFrEF due to IHD, 3D-TTE was a better predictor than 2D-TTE of in-hospital all-cause mortality.
Conflict of interest statement
None.
Figures

Similar articles
-
Transthoracic 3D Echocardiographic Left Heart Chamber Quantification Using an Automated Adaptive Analytics Algorithm.JACC Cardiovasc Imaging. 2016 Jul;9(7):769-782. doi: 10.1016/j.jcmg.2015.12.020. Epub 2016 Jun 15. JACC Cardiovasc Imaging. 2016. PMID: 27318718
-
[Evaluation of the clinical suitability of automated left ventricle's fraction and volume measurements in 3-dimensional echocardiography compared to values obtained in magnetic resonance imaging (pilot study)].Pol Merkur Lekarski. 2017 Oct 23;43(256):154-157. Pol Merkur Lekarski. 2017. PMID: 29084187 Polish.
-
Late Detection of Left Ventricular Dysfunction Using Two-Dimensional and Three-Dimensional Speckle-Tracking Echocardiography in Patients with History of Nonsevere Acute Myocarditis.J Am Soc Echocardiogr. 2017 Aug;30(8):756-762. doi: 10.1016/j.echo.2017.04.002. Epub 2017 Jun 7. J Am Soc Echocardiogr. 2017. PMID: 28599827
-
Prognostic Value of Advanced Echocardiography in Patients with Ischemic Heart Disease: A Comprehensive Review.Echocardiography. 2025 Jan;42(1):e70065. doi: 10.1111/echo.70065. Echocardiography. 2025. PMID: 39739970 Review.
-
Heart failure with severely reduced ejection fraction after liver transplantation: a case report and review of the literature.Acta Clin Belg. 2024 Feb;79(1):46-51. doi: 10.1080/17843286.2023.2278240. Epub 2024 Jan 2. Acta Clin Belg. 2024. PMID: 37927044 Review.
References
-
- Benjamin EJ, Virani SS, Callaway CW, et al. Heart disease and stroke statistics – 2018 update: A report from the American Heart Association. Circulation. 2018;137:e67–492. - PubMed
-
- Yancy CW, Jessup M, Bozkurt B, et al. 2017 ACC/AHA/HFSA focused update of the 2013 ACCF/AHA guideline for the management of heart failure: A report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America. J Cardiac Fail. 2017;23:628–51. - PubMed
-
- Cresci S, Pereira NL, Ahmad F, et al. Heart failure in the era of precision medicine: A scientific statement from the American Heart Association. Circ Genom Precis Med. 2019;12(10):458–85. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials